The Society for Clinical Research Sites (SCRS) welcomes BSI
Setting and pursuing strategic initiatives
The Society for Clinical Research Sites (SCRS) announced that BSI is a new Global Impact Partner (GIP). As a GIP, we are happy to serve on the SCRS Global Impact Board, working with the Leadership Council to set and pursue strategic initiatives.
The Society for Clinical Research Sites (SCRS) is a global trade organization founded in 2012 which represents almost 9,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.
We look forward to serving on the GIP and joining with Society for Clinical Research Sites (SCRS) to continue to facilitate improvements in the clinical trial space. This is another way that we can continue to gain insight into the issues that affect our customers and continue to help improve the clinical trial management experience for them.
We would like to express our gratitude for the warm welcome by SCRS: “Efficient software has become an important component of clinical trial operations,” said SCRS president, Christine Pierre. “As an innovator in CTMS software, we welcome BSI as a valued partner in promoting site sustainability.”
“We welcome BSI as valued partner and innovator for CTMS.”
Christine Pierre, SCRS president
On November 9, 2017 the BSI CTMS community will meet for the 7th BSI CTMS User Group Meeting in the Kameha Grand Hotel in Zurich. Not only to celebrate the 10th birthday of the software but also to get a preview of the latest cloud-based release, named Denim. Through the visionary Web interface, implemented in HTML5, the revolutionary CTMS generation also fits perfectly all mobile end-devices like your favorite pair of jeans. In addition to the refreshing and modern user experience, BSI CTMS Denim awaits with new and practical functions. These include modules for diagnostic trials, new reporting features, upgrades to existing modules, risk assessment for trials and trial centers, and much more.